This episode, sponsored by an educational grant from Sanofi Genzyme and Regeneron, is the final instalment in a five-part series exploring the subject of atopic dermatitis (AD).

This week, Jonathan sits down with three leaders from the charity accelerator The Voluntary Solidarity Fund (VSF) to discuss the topic of marginalisation.

This episode, sponsored by an educational grant from Amarin Corporation, is a discussion around primary prevention and treatment of atherosclerotic cardiovascular disease (ASCVD).

Rodrigo Garcia, Head of Patient Centricity, Recruitment and Retention, EMD Serono, discusses the importance of diverse clinical trials.

This week, Jonathan muses on the importance of emerging from the pandemic safely, addressing conspiracy theories, vaccine hesitancy, public uncertainty, and the role of strong leadership, all through an analogy of aviation.

PSA remains the gold standard as a first-line screening test, but is limited in terms of specificity, especially among older men. We now have available new, non-invasive biomarkers which can help men decide whether to proceed with biopsy, in order to find high-grade, potentially lethal tumors early while minimizing over-diagnosis of low-grade, indolent tumors.